Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndromeRubén Deogracias, Morteza Yazdani, Martijn P J Dekkers, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approachJacky Guy, Elena Hein, Bea Alexander-Howden, et al.Journal of Proteomics|October 20, 2019
Brain protein changes in Mecp2 mouse mutant models: Effects on disease progression of Mecp2 brain specific gene reactivationAlessio Cortelazzo, Claudio De Felice, Jacky Guy, et al.Epigenetics & Chromatin|August 30, 2014
DNA methylation reader MECP2: cell type- and differentiation stage-specific protein distributionCongdi Song, Yana Feodorova, Jacky Guy, et al.Human Molecular Genetics|December 10, 2015
The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndromeKyla Brown, Jim Selfridge, Sabine Lagger, et al.Nature|October 12, 2017
Radically truncated MeCP2 rescues Rett syndrome-like neurological defectsRebekah Tillotson, Jim Selfridge, Martha V Koerner, et al.Brain : a Journal of Neurology|April 25, 2012
Morphological and functional reversal of phenotypes in a mouse model of Rett syndromeLianne Robinson, Jacky Guy, Leanne McKay, et al.Science (New York, N.Y.)|July 20, 2002
Enhanced CpG mutability and tumorigenesis in MBD4-deficient miceCatherine B Millar, Jacky Guy, Owen J Sansom, et al.Human Molecular Genetics|July 9, 2005
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndromeUlrike A Nuber, Skirmantas Kriaucionis, Tim C Roloff, et al.Genes & Development|November 23, 2018
Toxicity of overexpressed MeCP2 is independent of HDAC3 activityMartha V Koerner, Laura FitzPatrick, Jim Selfridge, et al.Pageof 3